During 2023 Microviable Therapeutics has attended several leading events in the fields of microbiota, pharma and investment. In some cases we have participated as speakers with presentations and posters. This is the case of Microbiome [...]
Claudio Hidalgo, CEO at Microviable, will be attending BioSpain 2023, one of the largest international biotechnology events in southern Europe, will take place from 26-28 September 2023 in Barcelona thanks to a coordinated collaboration of [...]
Microviable Therapeutics Research Scientist Pilar Manrique will be presenting at Microbiome Connect Europe 2023 taking place on July 5th-6th at Amsterdam. Pilar will discuss "A path to develop a donor-based microbiome therapeutic product". Microbiome Connect [...]
Microviable Therapeutics is thrilled to announce that will be attending the Microbiome & Probiotic R&D & Business Collaboration Forum taking place on May 23rd-24th at Rotterdam. The event will bring together academic, industry, and investment [...]
Microviable Therapeutics was selected to present at Anglonordic Life Science Conference 2023, taking place on April 20th in London. Exclusively selected attendees will represent the key drivers of the European life sciences growth sector. Microviable's [...]
Microviable Therapeutics will be attending the XIV Workshop of SEMiPYP (Spanish Society of Microbiota, Probiotics and Prebiotics) taking place on March 8th-10th at Pamplona. The event will make special mention of the new advances in [...]
Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and our CBO, Rafael M. Permuy, MBA, will be attending BIO-Europe event in Leipzig, Germany, from October 24th to 26th. BIO-Europe® is the preeminent partnering conference for the [...]
Microviable Therapeutics will be presenting at I Asturias International Meeting on Clinical Microbiology and Infectious Disease (AIMID 2022) on September 22-23. Claudio Hidalgo, CEO at Microviable, will discuss the use of “Microbiome-derived biotherapeutic products for [...]